资讯 Merck Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manif 2026-05-07
资讯 Chiesi Group to Acquire KalVista Pharmaceuticals, Expanding its Global Rare Disease Portfolio 2026-05-07
